Cabozantinib Dosage Form and Use in the Treatment of Cancer
- 专利权人:
- INC.;EXELIXIS
- 发明人:
- Arthur DeCillis
- 申请号：
- US14782537
- 公开号：
- US20160022662A1
- 申请日:
- 2014.04.04
- 申请国别(地区):
- US
- 年份:
- 2016
- 代理人:
- 摘要：
- This invention relates to a dosage form of cabozantinib and a method of employing the dosage form to treat cancer.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- Hydrophilic foam and pharmaceutical dosage form employing the same
- Antihistamine and decongestant system
- THERAPEUTIC METHODS EMPLOYING NORIBOGAINE AND RELATED COMPOUNDS
- Treatment of proliferative disorders with a chemiluminescent agent
- TREATMENT OF PROLIFERATIVE DISORDERS WITH A CHEMILUMINESCENT AGENT
